CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

184 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder

NCT00050050

Attention Deficit Disorder With Hyperactivity

COMPLETED PHASE1

Long-Term Effects of CBT on Quality of Life in Adults With ADHD

NCT05290311

Attention Deficit Hyperactivity Disorder

COMPLETED

Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder

NCT02210728

Attention Deficit Hyperactivity Disorder

UNKNOWN NA

Cognitive Behavioral Therapy for University Students Diagnosed With Attention-deficit Hyperactivity Disorder (ADHD)

NCT04714866

Attention-deficit Hyperactivity

UNKNOWN NA

CBT Group for Adolescents With ADHD: a Randomized Controlled Trial

NCT02172183

Attention Deficit Hyperactivity Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Attention Deficit Hyperactivity Disorder(ADHD) is an important comorbid condition in patients with substance use disorders (SUD). The prevalence of ADHD in patients with SUD is estimated 23%, and ADHD is associated with an untoward prognosis of SUD. However, adequate treatment programs for patients with ADHD and SUD are not available. Results of medication trials for patients with ADHD and SUD are disappointing, and cognitive behavioral therapy (CBT) has not yet been investigated in this population. In patients with ADHD without comorbid SUD, the results of CBT in randomized trials are positive. The purpose of this study is to investigate if CBT is effective in treating ADHD symptoms in patients with ADHD and SUD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit Hyperactivity Disorder Substance Use Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard addiction treatment

10 sessions of standard addiction treatment. No ADHD treatment.

Group Type NO_INTERVENTION

No interventions assigned to this group

addiction treatment and ADHD treatment

10 sessions cognitive behavioral therapy on addiction treatment combined with 5 sessions on ADHD treatment.

Group Type EXPERIMENTAL

cognitive behavioral therapy for treating ADHD symptoms

Intervention Type BEHAVIORAL

5 sessions of one hour CBT for treating ADHD symptoms by a trained health care worker

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cognitive behavioral therapy for treating ADHD symptoms

5 sessions of one hour CBT for treating ADHD symptoms by a trained health care worker

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* substance use disorder
* ADHD
* able to comply with study activities

Exclusion Criteria

* severe neurological or psychiatric diseases (for example Parkinson, dementia, psychosis, bipolar depression) which require medication
* unable to read or write Dutch language

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No